Regulated information

Programme de rachat - November 2017 (french)

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

Information hebdomadaire relative aux transactions réalisées sur ses propres titres (20 au 24 juin 2016)

Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers 

2018 sales: up 3.2% to €367.9 million

9.1% GROWTH IN ESSENTIALS PRODUCTS AT CONSTANT EXCHANGE RATES

Programme de rachat - January 2019 (french)

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

Growth in all financial indicators in 2018. Essentials products sales: €179.4M (up 9.1% at constant exchange rates). Net income group share €36.3M (up 4.0%)

At its meeting on March 19, 2019, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited 2018 financial statements.

Vetoquinol signs agreement to acquire Clarion Biociênciasin Brazil

On April 3rd, Vetoquinol signed an agreement to acquire Clarion Biociências, a Brazilian veterinary laboratory based in the state of Goiás.

Vetoquinol finalizes acquisition of Clarion Biociencias in Brazil

Lure (France), April 16, 2019 - Vetoquinol today confirms the completion of its acquisition of Clarion Biociências, a Brazilian veterinary laboratory based in the state of Goiás.

Q1 2019 sales: €90.9 million (up 3.7%)

Vetoquinol Group sales for Q1 2019 amounted to €90.9 million, up 2.3% at constant exchange rates and up 3.7% as reportedfrom the same period last year.

Information hebdomadaire relative aux transactions réalisées sur ses propres titres (26 avril 2019)

Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers 

Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2018 (french version)